Pages that link to "Q43514458"

The following pages link to Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays (Q43514458):

Displaying 22 items.

• A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study (Q24651897) (← links)
• Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation (Q24655104) (← links)
• Factors affecting the accuracy of a class prediction model in gene expression data (Q30975559) (← links)
• Translating microarray data for diagnostic testing in childhood leukaemia (Q31062604) (← links)
• Microarray based diagnosis profits from better documentation of gene expression signatures (Q33320174) (← links)
• Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia (Q34792856) (← links)
• Evaluation of gene expression classification studies: factors associated with classification performance (Q35158226) (← links)
• Diagnosis of Coronary Heart Diseases Using Gene Expression Profiling; Stable Coronary Artery Disease, Cardiac Ischemia with and without Myocardial Necrosis (Q38630654) (← links)
• Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. (Q36402208) (← links)
• Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives. (Q37808658) (← links)
• Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses. (Q37829956) (← links)
• Machine learning applications for prediction of relapse in childhood acute lymphoblastic leukemia. (Q38636061) (← links)
• Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia (Q40764658) (← links)
• The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia (Q42741956) (← links)
• Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index (Q46731902) (← links)
• Annotation-based distance measures for patient subgroup discovery in clinical microarray studies (Q48395885) (← links)
• Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia (Q50267725) (← links)
• Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status (Q50775513) (← links)
• Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia. (Q52927198) (← links)
• Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics. (Q54538015) (← links)
• What happens if you pose the wrong questions? (Q85030758) (← links)
• Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review (Q98779175) (← links)